Draghia-Akli Ruxandra sold NVAX
November 11, 2025 · Form 4 insider transaction
Draghia-Akli Ruxandra sold 14,257 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
14,257
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeD: Disposition to the issuer
Transaction dateNovember 11, 2025
Filing dateNovember 13, 2025
Shares owned after28,513
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.; One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.